Article
Minimizing time in culture: A prototypic autologous manufacturing workflow for monoclonal iPSC lines within seven weeks
2026-08-10
Abstract excerpt
Induced pluripotent stem cells (iPSCs) hold great promise for both allogeneic and autologous cellular therapies. However, broad application and clinical translation is hindered by fragmented, complex and time-intensive workflows, resulting in high manufacturing costs, poor standardization and increased risk of genomic aberrations in derived iPSCs. In this study we developed a standardizable, automatable and time-...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a5e10d7b-ad2a-5545-8121-380f00babc31
- DOI
- 10.64898/2026.08.04.741960
